Middle East & Africa Parenteral Nutrition Market Forecast to 2030

At 4.1% CAGR, Middle East & Africa Parenteral Nutrition Market is Speculated to be Worth US$ 288.90 Million by 2030, says the Research Team

According to the Research Team’ research, the Middle East & Africa parenteral nutrition market was valued at US$ 208.88 million in 2022 and is expected to reach US$ 288.90 million by 2030, registering a CAGR of 4.1% from 2022 to 2030. Rise in prevalence of gastrointestinal diseases and innovation in formulations of nutrition products are among the critical factors attributed to the Middle East & Africa parenteral nutrition market expansion.

Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and gastric cancer are a few examples of gastrointestinal diseases. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” published in January 2021, functional gastrointestinal disorders have affected over 40% of people across the globe.

Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019. Ulcerative colitis and Crohn’s disease are two of the commonly diagnosed IBDs. Crohn’s disease is a complex, chronic disorder primarily affecting the digestive system. According to the IBS Global Impact Report, in 2016, the Middle East and African populations had a prevalence rate of irritable bowel syndrome of 5.8%. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of the colon, abnormal composition of serotonin in the colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. Further, chronic inflammation and reduced immunosurveillance caused by IBD may contribute to the development of gastric cancer.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They might also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Hence, medical nutrition is recommended for gastrointestinal disease patients as they are unable to ingest food. Further, the parenteral routes are preferred to provide them with essential nutrients. Some people might not show compatibility with tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs as they are diagnosed with diseases such as cancer and chronic diseases, which affect the gastrointestinal tract. This type of nutrition is highly preferred as a therapy option for most patients suffering from severe SBS. Therefore, the growing prevalence of gastrointestinal diseases drives the parenteral nutrition market.

On the contrary, mechanical, gastrointestinal, and metabolic complications associated with parenteral feeding systems hampers the growth of Middle East & Africa parenteral nutrition market.

Based on nutrient type, the Middle East & Africa parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held 33.1% market share in 2022, amassing US$ 69.21 million. It is projected to garner US$ 95.16 million by 2030 to register 4.1% CAGR during 2022-2030.

In terms of end user, the Middle East & Africa parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held 59.3% share of Middle East & Africa parenteral nutrition market in 2022, amassing US$ 123.95 million. It is projected to garner US$ 168.62 million by 2030 to expand at 3.9% CAGR during 2022-2030.

Based on country, the Middle East & Africa parenteral nutrition market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 35.5% share of Middle East & Africa parenteral nutrition market in 2022. It was assessed at US$ 73.92 million in 2022 and is likely to hit US$ 108.83 million by 2030, exhibiting a CAGR of 5.0% during 2022-2030.

Key players operating in the Middle East & Africa parenteral nutrition market are ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG, among others.

In March 2020, Fresenius Kabi AG announced the receiving of FDA approval for its SMOFlipid lipid injectable emulsion. The injection is intended for pediatric patients, including term and preterm neonates in the United States. The product is the first and only four-oil lipid emulsion for parenteral nutrition patients of every age. The SMOFlipid can be used in all facility centers.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa parenteral nutrition market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa parenteral nutrition market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Parenteral Nutrition Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 Growing Healthcare Expenditure in Middle East & Africa Region
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market – Middle East & Africa Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
6. Middle East & Africa Parenteral Nutrition Market Analysis – by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Parenteral Nutrition Market Analysis – by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Parenteral Nutrition Market – Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
8.1.1.1 Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Saudi Arabia: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 Saudi Arabia: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 United Arab Emirates: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 United Arab Emirates: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 South Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 South Africa: Parenteral Nutrition Market Breakdown, by End User
8.1.1.4 Rest of Middle East & Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Rest of Middle East & Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Rest of Middle East & Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.4.4 Rest of Middle East & Africa: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Vifor Pharma Management AG
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The the Reporting Teams
11.2 Glossary of Terms

LIST OF TABLES

Table 1. Parenteral Nutrition Market Segmentation
Table 2. Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 3. Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 4. United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 5. United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 6. South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 7. South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 8. Rest of Middle East & Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 9. Rest of Middle East & Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 10. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 11. Glossary of Terms, Parenteral Nutrition Market

LIST OF FIGURES

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Parenteral Nutrition Market Share (%) – by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) – by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Middle East & Africa: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 16. Middle East & Africa: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 19. South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 20. Rest of Middle East & Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)